Innovent Biologics, Inc. (01801.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

18.9x

Market Cap

HKD 93.07B

MomentumView details →

1D Return

−0.19%

YTD Return

+34.30%

RSI (14)

58.0

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

18.9x

Market Cap

HKD 93.07B

RSI (14)

58.0

MomentumView details →

1D Return

−0.19%

YTD Return

+34.30%

ProfitabilityView details →

Gross Margin

79.00%

Net Margin

8.69%

EBITDA Margin

12.17%

ROE (TTM)

11.32%

ROA (TTM)

5.64%

Asset Turnover

0.68x

GrowthView details →

Revenue YoY

+116.51%

EPS YoY

+180.55%

FCF YoY

+419.07%

Revenue CAGR 3Y

+41.98%

EPS CAGR 3Y

+926.16%

EBITDA YoY

+207.05%

EarningsView details →

EPS (Actual)

HKD 0.81

EPS Surprise

49.08%

Beats (12Q)

1/12

Next Q EPS Est

—

Avg Surprise (4Q)

49.08%

Rev Surprise

−3.28%

Capital & dividendView details →

Debt/Equity

0.11x

Current Ratio

2.68x

Quick Ratio

2.48x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

27.01B

Net Income (TTM)

2.35B

Op. CF (TTM)

11.60B

Next earningsMar 31, 2027 →

Latest newsMore news →

Innovent Biologics reported interim results for the period, with net profit up 50.2% year-on-year and adjusted net profit up 40.5% year-on-year, both significantly beating market expectations.9d ago

Innovent Biologics announced its interim results for the six months ended June 2026, with net profit up 50.2% to RMB 1.253 billion.10d ago

Similar companies

Akeso, Inc.09926.HK CG Invites Co., Ltd.083790.KQ MedPacto, Inc.235980.KQ iNtRON Biotechnology, Inc.048530.KQ Sino Biopharmaceutical Limited01177.HK Regeneron Pharmaceuticals, Inc.REGN Find similar companies →

Latest newsMore news →

Innovent Biologics reported interim results for the period, with net profit up 50.2% year-on-year and adjusted net profit up 40.5% year-on-year, both significantly beating market expectations.9d ago Innovent Biologics announced its interim results for the six months ended June 2026, with net profit up 50.2% to RMB 1.253 billion.10d ago Hacker group FulcrumSec leaked 1.2 terabytes of data stolen from Danish pharmaceutical company Novo Nordisk on the open internet on 12 August 2026, following an earlier sample leak on 17 July 2026.15d ago